Pancuronium Bromide Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1 mg/mL, 2 mg/mL

Reference Brands: Pavulon (USA/EU)

Category: Anaesthetics

Pancuronium bromide is available in Injection and strengths such as 1 mg/mL, 2 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Pancuronium bromide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Pancuronium bromide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Pancuronium bromide is a long-acting, non-depolarizing neuromuscular blocking agent belonging to the bis-quaternary aminosteroid class. First synthesized in 1964, it was developed as an alternative to earlier neuromuscular blockers such as d-tubocurarine, offering improved hemodynamic stability and minimal histamine release. Pancuronium bromide produces skeletal muscle relaxation by competitively blocking acetylcholine at the neuromuscular junction, thereby preventing nerve impulse transmission to muscle fibers.

Clinically, pancuronium bromide has been used to facilitate endotracheal intubation, provide muscle relaxation during surgical procedures, and support mechanical ventilation in anesthesia and intensive care settings. However, with the introduction of intermediate-acting neuromuscular blocking agents such as vecuronium, rocuronium, atracurium, and cisatracurium, the routine use of pancuronium has declined due to its prolonged duration of action, long elimination half-life, and predominant renal clearance.

Despite reduced clinical preference in modern anesthesia practice, pancuronium bromide remains relevant in specific therapeutic contexts where long-lasting neuromuscular blockade is required. The drug is marketed under the brand name Pavulon and continues to be produced for controlled medical and institutional use.